Akero Therapeutics, Inc. - AKRO

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 4.1% 3,397,779 View
Feb 17, 2026 SCHEDULE 13G/A RTW Investments, LP 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A Roderick Wong 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Capital, LP 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A David Kroin 0.0% 0 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Management Group LLP 0.0% 0 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Group Holdings LLP 0.0% 0 View
Feb 10, 2026 SCHEDULE 13G/A Wellington Investment Advisors Holdings LLP 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 7.9% 6,280,305 View
Nov 14, 2025 SCHEDULE 13G/A T. Rowe Price Associates, Inc. 4.8% 3,810,076 View
Nov 12, 2025 SCHEDULE 13G Wellington Management Group LLP 5.3% 4,251,861 View
Nov 12, 2025 SCHEDULE 13G Wellington Group Holdings LLP 5.3% 4,251,861 View
Nov 12, 2025 SCHEDULE 13G Wellington Investment Advisors Holdings LLP 5.3% 4,251,861 View
Nov 12, 2025 SCHEDULE 13G Wellington Management Company LLP 5.0% 4,251,861 View
Oct 07, 2025 SCHEDULE 13G Deep Track Capital, LP 5.5% 4,400,000 View
Oct 07, 2025 SCHEDULE 13G Deep Track Biotechnology Master Fund, Ltd. 5.5% 4,400,000 View
Oct 07, 2025 SCHEDULE 13G David Kroin 5.5% 4,400,000 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.